An ancient riboswitch class in bacteria regulates purine biosynthesis and one-carbon metabolism

Molecular Cell

Volumn 57, Issue 2, 2015, Pages 317-328

  Kim, Peter B ^a   Nelson, James W ^a   Breaker, Ronald R ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINOIMIDAZOLE 4 CARBOXAMIDE RIBONUCLEOTIDE; 5 AMINOIMIDAZOLE 4 CARBOXAMIDE RIBOSIDE 5' TRIPHOSPHATE; BETA GALACTOSIDASE; FOLIC ACID; PURINE; RIBONUCLEOTIDE; UNCLASSIFIED DRUG; BACTERIAL RNA; PURINE DERIVATIVE; RIBOSWITCH;

ARTICLE; BACILLUS SUBTILIS; BACTERIA; BACTERIAL CELL; BASE PAIRING; BINDING AFFINITY; CARBON METABOLISM; ENZYME ACTIVITY; GENE CONTROL; GENE EXPRESSION; HYDROGEN BOND; IN VIVO STUDY; LIGAND BINDING; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONE CARBON METABOLISM; PROTEIN SECONDARY STRUCTURE; PURINE SYNTHESIS; REPORTER GENE; RIBOSWITCH; RNA BINDING; RNA CLEAVAGE; RNA STRUCTURE; STREPTOCOCCUS THERMOPHILUS; STRESS; BIOSYNTHESIS; CLOSTRIDIUM ACETOBUTYLICUM; GENE EXPRESSION REGULATION; GENETICS; INVERTED REPEAT; MOLECULAR GENETICS;

BACTERIA (MICROORGANISMS);

BASE SEQUENCE; CLOSTRIDIUM ACETOBUTYLICUM; CONSERVED SEQUENCE; GENE EXPRESSION REGULATION, BACTERIAL; INVERTED REPEAT SEQUENCES; MOLECULAR SEQUENCE DATA; PURINES; RIBOSWITCH; RNA, BACTERIAL;

EID: 84921493496     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2015.01.001     Document Type: Article

References (60)

1. Ames T.D., Rodionov D.A., Weinberg Z., Breaker R.R. A eubacterial riboswitch class that senses the coenzyme tetrahydrofolate. Chem. Biol. 2010, 17:681-685.
2. Babu M.M., Luscombe N.M., Aravind L., Gerstein M., Teichmann S.A. Structure and evolution of transcriptional regulatory networks. Curr. Opin. Struct. Biol. 2004, 14:283-291.
3. Baker J.L., Sudarsan N., Weinberg Z., Roth A., Stockbridge R.B., Breaker R.R. Widespread genetic switches and toxicity resistance proteins for fluoride. Science 2012, 335:233-235.
4. Barrick J.E., Corbino K.A., Winkler W.C., Nahvi A., Mandal M., Collins J., Lee M., Roth A., Sudarsan N., Jona I., et al. New RNA motifs suggest an expanded scope for riboswitches in bacterial genetic control. Proc. Natl. Acad. Sci. USA 2004, 101:6421-6426.
5. Becker A., Fritz-Wolf K., Kabsch W., Knappe J., Schultz S., Volker Wagner A.F. Structure and mechanism of the glycyl radical enzyme pyruvate formate-lyase. Nat. Struct. Biol. 1999, 6:969-975.
6. Bochner B.R., Ames B.N. ZTP (5-amino 4-imidazole carboxamide riboside 5'-triphosphate): a proposed alarmone for 10-formyl-tetrahydrofolate deficiency. Cell 1982, 29:929-937.
7. Borovok I., Gorovitz B., Yanku M., Schreiber R., Gust B., Chater K., Aharonowitz Y., Cohen G. Alternative oxygen-dependent and oxygen-independent ribonucleotide reductases in Streptomyces: cross-regulation and physiological role in response to oxygen limitation. Mol. Microbiol. 2004, 54:1022-1035.
8. Breaker R.R. Riboswitches: from ancient gene-control systems to modern drug targets. Future Microbiol. 2009, 4:771-773.
9. Breaker R.R. Prospects for riboswitch discovery and analysis. Mol. Cell 2011, 43:867-879.
10. Breaker R.R. Riboswitches and the RNA world. Cold Spring Harb. Perspect. Biol. 2012, 4:4.
11. Cameron C.E., Castro C. The mechanism of action of ribavirin: lethal mutagenesis of RNA virus genomes mediated by the viral RNA-dependent RNA polymerase. Curr. Opin. Infect. Dis. 2001, 14:757-764.
12. Chakraborty S., Gruber T., Barry C.E., Boshoff H.I., Rhee K.Y. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. Science 2013, 339:88-91.
13. Daignan-Fornier B., Fink G.R. Coregulation of purine and histidine biosynthesis by the transcriptional activators BAS1 and BAS2. Proc. Natl. Acad. Sci. USA 1992, 89:6746-6750.
14. Daignan-Fornier B., Pinson B. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranosyl 5'-Monophosphate (AICAR), a Highly Conserved Purine Intermediate with Multiple Effects. Metabolites 2012, 2:292-302.
15. Dauber-Osguthorpe P., Roberts V.A., Osguthorpe D.J., Wolff J., Genest M., Hagler A.T. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins 1988, 4:31-47.
16. Derzelle S., Bolotin A., Mistou M.Y., Rul F. Proteome analysis of Streptococcus thermophilus grown in milk reveals pyruvate formate-lyase as the major upregulated protein. Appl. Environ. Microbiol. 2005, 71:8597-8605.
17. Deutscher J., Francke C., Postma P.W. How phosphotransferase system-related protein phosphorylation regulates carbohydrate metabolism in bacteria. Microbiol. Mol. Biol. Rev. 2006, 70:939-1031.
18. Fryer L.G., Parbu-Patel A., Carling D. Protein kinase inhibitors block the stimulation of the AMP-activated protein kinase by 5-amino-4-imidazolecarboxamide riboside. FEBS Lett. 2002, 531:189-192.
19. Gusarov I., Nudler E. The mechanism of intrinsic transcription termination. Mol. Cell 1999, 3:495-504.
20. Jenkins A., Cote C., Twenhafel N., Merkel T., Bozue J., Welkos S. Role of purine biosynthesis in Bacillus anthracis pathogenesis and virulence. Infect. Immun. 2011, 79:153-166.
21. Jungermann K.A., Schmidt W., Kirchniawy F.H., Rupprecht E.H., Thauer R.K. Glycine formation via threonine and serine aldolase. Its interrelation with the pyruvate formate lyase pathway of one-carbon unit synthesis in Clostridium kluyveri. Eur. J. Biochem. 1970, 16:424-429.
22. Kohanski M.A., Dwyer D.J., Collins J.J. How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 2010, 8:423-435.
23. Kopytek S.J., Dyer J.C., Knapp G.S., Hu J.C. Resistance tomethotrexate due to AcrAB-dependent export from Escherichia coli. Antimicrob. Agents Chemother. 2000, 44:3210-3212.
24. Kuznetsov J.N., Leclerc G.J., Leclerc G.M., Barredo J.C. AMPK and Akt determine apoptotic cell death following perturbations of one-carbon metabolism by regulating ER stress in acute lymphoblastic leukemia. Mol. Cancer Ther. 2011, 10:437-447.
25. Kwon Y.K., Higgins M.B., Rabinowitz J.D. Antifolate-induced depletion of intracellular glycine and purines inhibits thymineless death in E. coli. ACS Chem. Biol. 2010, 5:787-795.
26. Lanner J.T., Georgiou D.K., Dagnino-Acosta A., Ainbinder A., Cheng Q., Joshi A.D., Chen Z., Yarotskyy V., Oakes J.M., Lee C.S., et al. AICAR prevents heat-induced sudden death in RyR1 mutant mice independent of AMPK activation. Nat. Med. 2012, 18:244-251.
27. Lee E.R., Baker J.L., Weinberg Z., Sudarsan N., Breaker R.R. An allosteric self-splicing ribozyme triggered by a bacterial second messenger. Science 2010, 329:845-848.
28. Locasale J.W. Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 2013, 13:572-583.
29. Longo-Sorbello G.S., Bertino J.R. Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. Haematologica 2001, 86:121-127.
30. Meyer M.M., Hammond M.C., Salinas Y., Roth A., Sudarsan N., Breaker R.R. Challenges of ligand identification for riboswitch candidates. RNA Biol. 2011, 8:5-10.
31. Narkar V.A., Downes M., Yu R.T., Embler E., Wang Y.X., Banayo E., Mihaylova M.M., Nelson M.C., Zou Y., Juguilon H., et al. AMPK and PPARdelta agonists are exercise mimetics. Cell 2008, 134:405-415.
32. Nelson J.W., Sudarsan N., Furukawa K., Weinberg Z., Wang J.X., Breaker R.R. Riboswitches in eubacteria sense the second messenger c-di-AMP. Nat. Chem. Biol. 2013, 9:834-839.
33. Payne D.J., Gwynn M.N., Holmes D.J., Pompliano D.L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 2007, 6:29-40.
34. Pinson B., Vaur S., Sagot I., Coulpier F., Lemoine S., Daignan-Fornier B. Metabolic intermediates selectively stimulate transcription factor interaction and modulate phosphate and purine pathways. Genes Dev. 2009, 23:1399-1407.
35. Rébora K., Laloo B., Daignan-Fornier B. Revisiting purine-histidine cross-pathway regulation in Saccharomyces cerevisiae: a central role for a small molecule. Genetics 2005, 170:61-70.
36. Rodionov D.A., Gelfand M.S. Identification of a bacterial regulatory system for ribonucleotide reductases by phylogenetic profiling. Trends Genet. 2005, 21:385-389.
37. Rohlman C.E., Matthews R.G. Role of purine biosynthetic intermediates in response to folate stress in Escherichia coli. J.Bacteriol. 1990, 172:7200-7210.
38. Sabina R.L., Holmes E.W., Becker M.A. The enzymatic synthesis of 5-amino-4-imidazolecarboxamide riboside triphosphate (ZTP). Science 1984, 223:1193-1195.
39. Sabina R.L., Patterson D., Holmes E.W. 5-Amino-4-imidazolecarboxamide riboside (Z-riboside) metabolism in eukaryotic cells. J.Biol. Chem. 1985, 260:6107-6114.
40. Sawers R.G. Formate and its role in hydrogen production in Escherichia coli. Biochem. Soc. Trans. 2005, 33:42-46.
41. Schirch V. Mechanisms of folate-requiring enzymes in one-carbonmetabolism. Comprehensive Biological Catalysis 1998, 211-252. Academic Press. M. Sinnott (Ed.).
42. Serganov A., Nudler E. A decade of riboswitches. Cell 2013, 152:17-24.
43. Serganov A., Patel D.J. Metabolite recognition principles and molecular mechanisms underlying riboswitch function. Annu. Rev. Biophys. 2012, 41:343-370.
44. Soukup G.A., Breaker R.R. Relationship between internucleotide linkage geometry and the stability of RNA. RNA 1999, 5:1308-1325.
45. Stephens J.C., Artz S.W., Ames B.N. Guanosine 5'-diphosphate 3'-diphosphate (ppGpp): positive effector for histidine operon transcription and general signal for amino-acid deficiency. Proc. Natl. Acad. Sci. USA 1975, 72:4389-4393.
46. Sudarsan N., Hammond M.C., Block K.F., Welz R., Barrick J.E., Roth A., Breaker R.R. Tandem riboswitch architectures exhibit complex gene control functions. Science 2006, 314:300-304.
47. Sudarsan N., Lee E.R., Weinberg Z., Moy R.H., Kim J.N., Link K.H., Breaker R.R. Riboswitches in eubacteria sense the second messenger cyclic di-GMP. Science 2008, 321:411-413.
48. Suh J.R., Herbig A.K., Stover P.J. New perspectives on folate catabolism. Annu. Rev. Nutr. 2001, 21:255-282.
49. Sullivan J.E., Carey F., Carling D., Beri R.K. Characterisation of5'-AMP-activated protein kinase in human liver using specific peptide substrates and the effects of 5'-AMP analogues on enzyme activity. Biochem. Biophys. Res. Commun. 1994, 200:1551-1556.
50. Swinney D.C., Anthony J. How were new medicines discovered?. Nat. Rev. Drug Discov. 2011, 10:507-519.
51. Trausch J.J., Ceres P., Reyes F.E., Batey R.T. The structure of a tetrahydrofolate-sensing riboswitch reveals two ligand binding sites in a single aptamer. Structure 2011, 19:1413-1423.
52. Wei J.R., Krishnamoorthy V., Murphy K., Kim J.H., Schnappinger D., Alber T., Sassetti C.M., Rhee K.Y., Rubin E.J. Depletion of antibiotic targets has widely varying effects on growth. Proc. Natl. Acad. Sci. USA 2011, 108:4176-4181.
53. Weinberg Z., Wang J.X., Bogue J., Yang J., Corbino K., Moy R.H., Breaker R.R. Comparative genomics reveals 104 candidate structured RNAs from bacteria, archaea, and their metagenomes. Genome Biol. 2010, 11:R31.
54. White H.B. Coenzymes as fossils of an earlier metabolic state. J.Mol. Evol. 1976, 7:101-104.
55. Wickiser J.K., Cheah M.T., Breaker R.R., Crothers D.M. The kinetics of ligand binding by an adenine-sensing riboswitch. Biochemistry 2005, 44:13404-13414.
56. Wickiser J.K., Winkler W.C., Breaker R.R., Crothers D.M. The speed of RNA transcription and metabolite binding kinetics operate an FMN riboswitch. Mol. Cell 2005, 18:49-60.
57. Wiesner J.B., Ugarkar B.G., Castellino A.J., Barankiewicz J., Dumas D.P., Gruber H.E., Foster A.C., Erion M.D. Adenosine kinase inhibitors as a novel approach to anticonvulsant therapy. J.Pharmacol. Exp. Ther. 1999, 289:1669-1677.
58. Woese C.R. The genetic code; the molecular basis for genetic expression 1967, Harper & Row, New York.
59. Yarnell W.S., Roberts J.W. Mechanism of intrinsic transcription termination and antitermination. Science 1999, 284:611-615.
60. Zheng W., Thorne N., McKew J.C. Phenotypic screens as a renewed approach for drug discovery. Drug Discov. Today 2013, 18:1067-1073.